drugset / Trial / NCT07234864
Study to Assess Safety, Tolerability, PK, and PD of Multiple Doses of ZE63-0302 Administrated Orally in T2DM Patients.
RandomizedSequentialDouble-blindTreatment
Summary
A Phase 1b study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of multiple doses of ZE63-0302 administrated orally in T2DM patients.
Timeline
- Start
- 2025-11-19
- Primary completion
- 2026-04-21
- Completion
- 2026-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ZE63-0302 | Unknown | — | Oral |